Lukáš M - Search Results

1

Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases.

Malíčková K, Ďuricová D, Bortlík M, Janatková I, Zima T, Lukáš M. Malíčková K, et al. Among authors: lukas m. Auto Immun Highlights. 2012 Dec 23;4(1):27-32. doi: 10.1007/s13317-012-0045-0. eCollection 2013 Apr. Auto Immun Highlights. 2012. PMID: 26000139 Free PMC article.

2

Deficiency of Adenomatous Polyposis Coli protein in sporadic colorectal adenomas and its associations with clinical phenotype and histology.

Bortlik M, Vitkova I, Papezova M, Kohoutova M, Novotny A, Adamec S, Chalupna P, Lukas M. Bortlik M, et al. Among authors: lukas m. World J Gastroenterol. 2006 Jun 28;12(24):3901-5. doi: 10.3748/wjg.v12.i24.3901. World J Gastroenterol. 2006. PMID: 16804979 Free PMC article.

3

What is the origin of ulcerative colitis? Still more questions than answers.

Lukas M, Bortlik M, Maratka Z. Lukas M, et al. Postgrad Med J. 2006 Oct;82(972):620-5. doi: 10.1136/pmj.2006.047035. Postgrad Med J. 2006. PMID: 17068271 Free PMC article. Review.

4

Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?

Malickova K, Lukas M, Donoval R, Sandova P, Janatkova I. Malickova K, et al. Among authors: lukas m. Clin Lab. 2006;52(11-12):631-8. Clin Lab. 2006. PMID: 17175895

5

Nonadherence in inflammatory bowel disease: results of factor analysis.

Cervený P, Bortlík M, Kubena A, Vlcek J, Lakatos PL, Lukás M. Cervený P, et al. Among authors: lukas m. Inflamm Bowel Dis. 2007 Oct;13(10):1244-9. doi: 10.1002/ibd.20189. Inflamm Bowel Dis. 2007. PMID: 17538983

6

Polymorphisms of the TPMT gene in the Czech healthy population and patients with inflammatory bowel disease.

Slanar O, Bortlík M, Buzková H, Donoval R, Pechandová K, Sebesta I, Lukás M, Perlík F. Slanar O, et al. Among authors: lukas m. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):835-8. doi: 10.1080/15257770802146478. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600549

7

Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?

Frol'ová L, Smetana K Jr, Borovská D, Kitanovicová A, Klimesová K, Janatková I, Malícková K, Lukás M, Drastich P, Benes Z, Tucková L, Manning JC, André S, Gabius HJ, Tlaskalová-Hogenová H. Frol'ová L, et al. Among authors: lukas m. Inflamm Res. 2009 Aug;58(8):503-12. doi: 10.1007/s00011-009-0016-8. Epub 2009 Mar 7. Inflamm Res. 2009. PMID: 19271150

8

Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis.

Lukas M, Drastich P, Konecny M, Gionchetti P, Urban O, Cantoni F, Bortlik M, Duricova D, Bulitta M. Lukas M, et al. Inflamm Bowel Dis. 2010 Jul;16(7):1180-6. doi: 10.1002/ibd.21161. Inflamm Bowel Dis. 2010. PMID: 19885903

9

Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort.

Malickova K, Lakatos PL, Bortlik M, Komarek V, Janatkova I, Lukas M. Malickova K, et al. Among authors: lukas m. Eur J Gastroenterol Hepatol. 2010 Feb;22(2):144-50. doi: 10.1097/MEG.0b013e32832f5c7e. Eur J Gastroenterol Hepatol. 2010. PMID: 19927001

10

Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes.

Malícková K, Kalousová M, Fucíková T, Bortlík M, Duricová D, Komárek V, Zima T, Janatková I, Lukás M. Malícková K, et al. Among authors: lukas m. Scand J Clin Lab Invest. 2010 Jul;70(4):294-9. doi: 10.3109/00365513.2010.485648. Scand J Clin Lab Invest. 2010. PMID: 20446880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters